Biomatter Closes Oversubscribed $18M Series A to Build AI Enzyme Labs

Astanor leads an oversubscribed $18M Series A in Biomatter, funding a 2,000-sq-m Vilnius lab the company says will cut enzyme design cycles from weeks to days by 2027.